Stay updated with breaking news from Tonus Elast. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Knee Orthosis Market Size, Status and Forecast 2021 The Global Knee Orthosis Market Research Report 2021-2026 is a valuable source of insightfu
Olainfarm: Audited annual report 2020 The Company reviewed operations in the main markets JSC Olainfarm continued investments to modernize its operations and worked on clinical trials Group's revenues in 2020 were EUR 122,157 thousand, net profit was EUR 9,478 thousand. Group actively engaged to improve operations and financial results of subsidiaries In 2020, JSC Olainfarm approved its new strategy "Forward! 2020-2025". The main goal is to become one of the TOP 10 largest pharmaceutical manufacturing companies in Central and Eastern Europe by 2025, sustainably supplying healthcare products a...
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...
Olainfarm A civil case has been initiated in the claim of JSC Olainfarm for the damage caused A civil case has been initiated in the claim of JSC Olainfarm for the damage caused Pursuant to the decision of the shareholders' meeting of September 22, 2020, the Management Board of JSC Olainfarm has filed a lawsuit against the former members of the Management Board of JSC Olainfarm. By the decision of the Vidzeme Suburb Court of Riga City on 12th of April 2021, a civil case has been initiated in the claim of JSC Olainfarm against former members of the Management Board who entered into an agreemen...
Information expressed in the public domain by the Repharm Group is deceptive and contradictory Today, on February 19, information has arrived in the public domain that the company from Repharm Group will acquire the shares of JSC “Olainfarm” directly and indirectly owned by Anna Emilija Maligina. The Chairman of the Management Board of JSC Olainfarm Jeroen Weites points out that Signe Baldere - Sildedze, the legal representative of Anna Emilija Maligina, has informed the Board of JSC Olainfarm that the information in the public domain is false and the deal entered with SIA Farma Fund (p...